- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT02170948
The Effectiveness of the Addition of Dexmedetomidine to Analgesia for Ankle Surgery.
The Analgesic Efficacy of Dexmedetomidine as a Local Anesthetic Adjunct in Ankle Blocks for Forefoot Surgery. A Dose Ranging Study.
Forefoot surgeries involve a relatively short operation usually completed in 1 - 1½ hours, with patients generally being allowed to go home on the same day. Despite this, post-surgery pain is often severe and a delay in the discharge of patients due to difficulty with pain control after the surgery is common.
Performing nerve blocks in association with sedation is the preferred way to provide pain relief and offers important benefits for foot surgeries. With nerve blocks, the requirement for oral painkillers and their associated side effects is reduced. Increasing the duration of local anesthetic action is helpful as it increases the time of pain relief, allowing for a smoother transition to oral pain medications, earlier discharge, and faster recovery.
Recently, Precedex has been considered for its usefulness in prolonging the pain relief produced by nerve blocks. The identified benefits of this particular use include reducing post-surgical pain medications requirements, reducing the incidence of nausea and vomiting, reducing the incidence of sedation from such medication, and diminishing the incidence of respiratory depression (inadequate breathing). Two small studies have also shown that adding dexmedetomidine to nerve block solution results in prolonging pain relief.
The purpose of the study is to examine several doses of dexmedetomidine combined with local anesthetic drugs and determine the best combination for prolonging pain relief, while minimizing potential side effects.
연구 개요
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Ontario
-
Toronto, Ontario, 캐나다, M5T 2S8
- Toronto Western Hospital
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- English Speaking
- American Society of Anesthesiologists (ASA) I-III patients
- Ages 18-65
- Body Mass Index (BMI) ≤ 38 kg/m2
Exclusion Criteria:
- Preexisting neurological deficits or peripheral neuropathy in the distribution of the sciatic or femoral nerves
- Known coronary heart disease, congestive heart failure, cardiomyopathies, or arrhythmias
- Baseline line heart rate < 60 Beats Per Minute (BPM) or baseline systolic blood pressure < 100 mm Hg
- Medications that reduce heart rate
- Known liver or renal dysfunction or existing diseases affecting these organs
- Local infection
- Contraindication to regional anesthesia
- Chronic pain disorders
- History of use of over 30mg oxycodone or equivalent per day
- Contraindication to a component of multi-modal analgesia
- Allergy to local anesthetics or dexmedetomidine
- History of significant psychiatric conditions that may affect patient assessment
- Pregnancy
- Inability to provide informed consent
- Patient refusal
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 삼루타
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Dex 0.5
Ropivacaine and Lidocaine plus Dexmedetomidine (0.5mg/kg) plus Normal Saline
|
An anesthetic concoction of 2% Lidocaine, 1% Ropivacaine, and Dexmedetomidine diluted solution will be provided via a series of anesthetic injections related to the ankle block procedure
다른 이름들:
|
|
실험적: Dex 1.0
Ropivacaine and Lidocaine plus Dexmedetomidine (1.0mg/kg) plus Normal Saline
|
An anesthetic concoction of 2% Lidocaine, 1% Ropivacaine, and Dexmedetomidine diluted solution will be provided via a series of anesthetic injections related to the ankle block procedure
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Duration of Analgesia
기간: patients will be followed for two weeks
|
Patients will be asked about the duration of their analgesia by asking when they first felt pain at the surgical site.
Patients will be asked prior to discharge, and routinely during specified phone calls until analgesia wear off
|
patients will be followed for two weeks
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Requirements for pain medications; complications
기간: weekly for up to 2 weeks
|
Patients will be called at 24 hours, 7 days and 14 days and asked to describe their pain levels, the requirements for pain medication, and any complications that may have arisen post-operatively.
|
weekly for up to 2 weeks
|
공동 작업자 및 조사자
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
키워드
추가 관련 MeSH 약관
기타 연구 ID 번호
- 13-6795-A
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Dexmedetomidine에 대한 임상 시험
-
Cairo University모병
-
Kafrelsheikh University완전한
-
Prince Sultan Military Medical City완전한
-
Ain Shams University완전한
-
Poznan University of Medical Sciences모병
-
University of North Carolina, Chapel HillWashington University School of Medicine; United States Department of Defense; University... 그리고 다른 협력자들모병
-
BioXcel Therapeutics IncCognitive Research Corporation완전한